Replies to post #1709 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

[OT] >IDIX seems more compelling at the moment. Assured revenue by 2010, ample cash on hand w/a bazzilion shorts on record.<

IDIX will have revenue from its approved drug (Tyzeka) in the current quarter: #msg-14283481.

Perhaps you meant to say profitability rather than revenue, but this too will come for IDIX before 2010.